NO scavenging by 3-hydroxyanthranilic acid and 3-hydroxykynurenine: N-nitrosation leads via oxadiazoles to o-quinone diazides

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 3, 2008, Pages 237-244

  Backhaus, Claudia ^a   Rahman, Hafizur ^a   Scheffler, Sebastian ^a   Laatsch, Hartmut ^a   Hardeland, Rüdiger ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

3 Hydroxyanthranilic acid; 3 Hydroxykynurenine; Aminophenol; Diazonium; Inflammation; Nitrosation; NO scavenging; Quinone diazide

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; 3 METHOXYANTHRANILIC ACID; ACETYLCYSTEINE; ANILINE DERIVATIVE; ANTHRANILIC ACID; ANTHRANILIC ACID DERIVATIVE; AZIDE; DIAZONIUM COMPOUND; KYNURENINE; NITRATE; NITRITE; NITROGEN; OXADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; NITROSATION; PH; PRIORITY JOURNAL; TOXICITY;

3-HYDROXYANTHRANILIC ACID; ACETYLCYSTEINE; AMINOPHENOLS; ANTHRANILIC ACIDS; CHROMATOGRAPHY, THIN LAYER; DIAZONIUM COMPOUNDS; FREE RADICAL SCAVENGERS; HYDRAZINES; INFLAMMATION; KYNURENINE; MAGNETIC RESONANCE IMAGING; MASS SPECTROMETRY; NITRIC OXIDE; NITRITES; NITROSATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXADIAZOLES; QUINONES; TRYPTOPHAN;

EID: 52349121940     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.07.002     Document Type: Article

References (42)

1. Hayaishi O. Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation. Adv. Exp. Med. Biol. 398 (1996) 285-289
2. Yasui H., Takai K., Yoshida R., and Hayaishi O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc. Natl. Acad. Sci. USA 83 (1986) 6622-6626
3. Pfefferkorn E.R., Rebhun S., and Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J. Interferon Res. 6 (1986) 267-279
4. Roy E.J., Takikawa O., Kranz D.M., Brown A.R., and Thomas D.L. Neuronal localization of indoleamine 2 3-dioxygenase in mice. Neurosci. Lett. 387 (2005) 95-99
5. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4 (2004) 762-774
6. Carlin J.M., Borden E.C., Sondel P.M., and Byrne G.I. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45 (1989) 29-34
7. Guillemin G.J., Smith D.G., Smythe G.A., Armati P.J., and Brew B.J. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv. Exp. Med. Biol. 527 (2003) 105-112
8. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance. immunosuppression by starvation?. Immunol. Today 20 (1999) 469-473
9. Mellor A.L., and Munn D.H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170 (2003) 5809-5813
10. Robinson C.M., Shirey K.A., and Carlin J.M. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-γ and tumor necrosis factor-α. J. Interferon Cytokine Res. 23 (2003) 413-421
11. Robinson C.M., Hale P.T., and Carlin J.M. The role of IFN-γ and TNF-α-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J. Interferon Cytokine Res. 25 (2005) 20-30
12. Alberati-Giani D., Ricciardi-Castagnoli P., Köhler C., and Cesura A.M. Regulation of the kynurenine metabolic pathway by interferon-γ in murine cloned macrophages and microglial cells. J. Neurochem. 66 (1996) 996-1004
13. Goldstein L.E., Leopold M.C., Huang X., Atwood C.S., Saunders A.J., Hartshorn M., Lim J.T., Faget K.Y., Muffat J.A., Scarpa R.C., Chylack Jr. LT., Bowden E.F., Tanzi R.E., and Bush A.I. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 39 (2000) 7266-7275
14. Vazquez S., Garner B., Sheil M.M., and Truscott R.J. Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions. Free Radic. Res. 32 (2000) 11-23
15. Thomas S.R., and Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep. 4 (1999) 199-220
16. Matsuo M., Nakamura N., Shidoji Y., Muto Y., Esaki H., and Osawa T. Antioxidative mechanism and apoptosis induction by 3-hydroxyanthranilic acid, an antioxidant in Indonesian food Tempeh, in the human hepatoma-derived cell line, HuH-7. J. Nutr. Sci. Vitaminol. Tokyo 43 (1997) 249-259
17. Sekkaï D., Guittet O., Lemaire G., Tenu J.-P., and Lepoivre M. Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthanilic acid, a tryptophan metabolite. Arch. Biochem. Biophys. 340 (1997) 117-123
18. Butler A.R., Flitney F.W., and Williams D.L.H. NO, nitrosonium ions, nitroxide ions and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol. Sci. 16 (1995) 18-22
19. Khan S., Kayahara M., Joashi U., Mazarakis N.D., Saraf C., Edwards A.D., Hughes M.N., and Mehmet H. Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. J. Cell Sci. 110 (1997) 2315-2322
20. Keefer L.K., Nims R.W., Davies K.M., and Wink D.A. "NONOates" (1-substituted diazen-1-ium-1,2-dillates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268 (1996) 281-293
21. 1-acetyl-5-methoxykynuramine (AMK). J. Pineal Res. 43 (2007) 382-388
22. Chiarugi A., Dello Sbarba P., Paccagnini A., Donnini S., Filippi S., and Moroni F. Combined inhibition of indoleamine 2 3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-γ-activated macrophages. J. Leukoc. Biol. 68 (2000) 260-266
23. Perez-Severiano F., Escalante B., and Rios C. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem. Res. 23 (1998) 1297-1302
24. Schwarcz R., and Pellicciari R. Manipulation of brain kynurenines: glial targets neuronal effects and clinical opportunities. J. Pharmacol. Exp. Ther. 303 (2002) 1-10
25. Perez-De La Cruz V., Gonzalez-Cortes C., Galvan-Arzate S., Medina-Campos O.N., Perez-Severiano F., Ali S.F., Pedraza-Chaverri J., and Santamaria A. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Neuroscience 135 (2005) 463-474
26. Mallozzi C., Martire A., Domenici M.R., Metere A., Popoli P., and Di Stasi A.M. L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: Involvement of src family kinases. J. Neurosci. Res. 85 (2007) 2770-2777
27. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43 (1994) 109-142
28. Barthberger M.D., Liu W., Ford E., Miranda K.M., Switzer C., Fukuto J.M., Farmer P.J., Wink D.A., and Houk K.N. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc. Natl. Acad. Sci. USA 99 (2002) 10958-10963
29. 1-acetyl-5-methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J. Pineal Res. 39 (2005) 251-260
30. 1-acetyl-5-methoxykynuramine contrasts with other tryptophan metabolites by a peculiar type of NO scavenging: cyclization to a cinnolinone prevents formation of unstable nitrosamines. J. Pineal Res. 43 (2007) 104-105
31. Best W.M., and Wege D. Intramolecular Diels-Alder additions of benzynes to furans. Exploratory studies. Aust. J. Chem. 40 (1986) 635-645
32. Blocher A., and Zeller K.-P. Naphtho[2,3-d][1,2,3]oxadiazol. Angew. Chem. 103 (1991) 1489-1490
33. Kato T., Tadokoro N., Tsutsui M., and Kikugawa K. Transformation of arylamines into direct-acting mutagens by reaction with nitrite. Mutat. Res. 249 (1991) 243-254
34. Christen S., Peterhans E., and Stocker R. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc. Natl. Acad. Sci. USA 87 (1990) 2506-2510
35. Poeggeler B., Thuermann S., Dose A., Schoenke M., Burkhardt S., and Hardeland R. Melatonin's unique radical scavenging properties-Roles of its functional substituents as revealed by a comparison with its structural analogs. J. Pineal Res. 33 (2002) 20-30
36. Hardeland R. Antioxidative protection by melatonin-Multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27 (2005) 119-130
37. Wu K., Bonin A.M., Leslie C.L., Baker R.S., and Stacey N.H. Genotoxicity and effects on rat liver drug-metabolizing enzymes by possible substitutes for 4, 4'-methylene bis(2-chloroaniline). Carcinogenesis 10 (1989) 2119-2122
38. Assmann N., Emmrich M., Kampf G., and Kaiser M. Genotoxic activity of important nitrobenzenes and nitroanilines in the Ames test and their structure-activity relationship. Mutat. Res. 395 (1997) 139-144
39. Brennan R.J., and Schiestl R.H. Diaminotoluenes induce intrachromosomal recombination and free radicals in Saccharomyces cerevisiae. Mutat. Res. 381 (1997) 251-258
40. Stiborova M., Miksanova M., Sulc M., Rydlova H., Schmeiser H.H., and Frei E. Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. Int. J. Cancer 116 (2005) 667-678
41. Guengerich F.P., Humphreys W.G., Yun C.H., Hammons G.J., Kadlubar F.F., Seto Y., Okazaki O., and Martin M.V. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues. Princess Takamatsu Symp. 23 (1995) 78-84
42. Marques M.M., Mourato L.L.G., Amorim M.T., Santos M.A., Melchior Jr. W.B., and Beland F.A. Effect of substitution site upon oxidation potentials of alkylanilines, the mutagenicities of N-hydroxyalkylanilines, and conformations of alkylaniline-DNA adducts. Chem. Res. Toxicol. 10 (1997) 1266-1274